000			01308nam a22003257a 4500
001			3523799
005			20150315091838.0
008			111206t1996 gb ||||| |||| 00| 0 eng d
010			_a 96012736
020			_a3540760180
040			_aDNLM/DLC _cDLC _dDLC
050	0	0	_aRC377 _b.M8435 1996
060	1	0	_aWL 360 M95635 1996
080			_a616-004
082	0	0	_a616.8/3406 _220
245	0	0	_aMultiple sclerosis : _badvances in clinical trial design, treatment, and future perspectives / _cD.E. Goodkin and R.A. Rudick (eds.).
260			_aLondon ; _aNew York : _bSpringer, _cc1996.
300			_axviii, 364 p. : _bill. ; _c25 cm.
504			_aIncludes bibliographical references and index.
650		0	_aMultiple sclerosis _xTreatment. _96962
650		0	_aClinical trials. _96963
650	1	2	_aMultiple Sclerosis _xtherapy. _96964
650	2	2	_aClinical Trials _xmethods. _96965
700	1		_aGoodkin, Donald E., _d1946- _96966
700	1		_aRudick, Richard A. _96967
906			_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg
942			_2udc _cBK
952			_w2011-08-31 _p2010-610734 _r2011-08-31 _40 _00 _bCPL _10 _o616-004 M-92 _d2010-10-21 _t2E58832 _70 _chall 5 _2udc _yBK _aCPL
999			_c2610 _d2610